McElhenny Sheffield Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-31	Closed	-$430	–	664
2022 Q4	$430	Buy	+31	New	+$4.71K	﹤0.01%	641

Other funds holding BHVN

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

LIP

Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return

McElhenny Sheffield Capital Management's BHVN Position: Q1 2023 in Review

McElhenny Sheffield Capital Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2023, closing a stake of 31 shares — an estimated $430 sold.

McElhenny Sheffield Capital Management first reported a position in BHVN in Q4 2022 and held it in 1 quarter. The position peaked at $430 in Q4 2022. 2 funds tracked by Wall St. Rank hold BHVN as of Q1 2023.

McElhenny Sheffield Capital Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2023 after selling out during the quarter.
McElhenny Sheffield Capital Management sold 31 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2023, an estimated $430.
McElhenny Sheffield Capital Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022 and held it in 1 quarter.
McElhenny Sheffield Capital Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $430 in Q4 2022.
2 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2023.

Based on McElhenny Sheffield Capital Management's 13F filing for Q1 2023, filed 13 Apr 2023.